Comparative Pharmacology of Bombesin Receptor Subtype-3, Nonpeptide Agonist MK-5046, a Universal Peptide Agonist, and Peptide Antagonist Bantag-1 for Human Bombesin Receptors
Paola Moreno(Hospital Universitario Fundación Jiménez Díaz), Robert T. Jensen(National Institutes of Health)
Cited by 35
Related Papers
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
|Annals of Oncology|2015|698
Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors
|JNCI Journal of the National Cancer Institute|2008|226
Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.
|PubMed|1998|98
Overexpression of Cyclin D1 Occurs Frequently in Human Pancreatic Endocrine Tumors<sup>1</sup>
|The Journal of Clinical Endocrinology & Metabolism|2000|78